|
US20030105294A1
(en)
*
|
1998-02-25 |
2003-06-05 |
Stephen Gillies |
Enhancing the circulating half life of antibody-based fusion proteins
|
|
US20050202538A1
(en)
*
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
|
ATE336514T1
(de)
|
2000-02-11 |
2006-09-15 |
Merck Patent Gmbh |
Steigerung der zirkulierenden halbwertzeit von auf antikörpern basierenden fusionsproteinen
|
|
BR0207854A
(pt)
|
2001-03-07 |
2004-08-24 |
Merck Patent Gmbh |
Tecnologia de expressão para proteìnas contendo uma porção de anticorpo de isotipo hìbrido
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
DK1383785T3
(da)
|
2001-05-03 |
2011-05-23 |
Merck Patent Gmbh |
Rekombinant tumorspecifikt antistof og anvendelse deraf
|
|
PT1454138E
(pt)
|
2001-12-04 |
2012-03-28 |
Merck Patent Gmbh |
Imunocitoquinas com seletividade modulada
|
|
ES2305886T3
(es)
|
2003-12-30 |
2008-11-01 |
Merck Patent Gmbh |
Proteinas de fusion de il-7 con porciones de anticuerpo, su preparacion y su empleo.
|
|
KR20060124656A
(ko)
*
|
2003-12-31 |
2006-12-05 |
메르크 파텐트 게엠베하 |
개선된 약물동태를 가지는 Ｆｃ-에리스로포이에틴 융합단백질
|
|
US7670595B2
(en)
*
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
US20070104689A1
(en)
*
|
2005-09-27 |
2007-05-10 |
Merck Patent Gmbh |
Compositions and methods for treating tumors presenting survivin antigens
|
|
BRPI0617664B8
(pt)
|
2005-10-21 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
uso de um anticorpo que reconhece a il-6 para a produção de uma composição farmacêutica para tratar o enfarte do miocárdio ou suprimir a remodelagem ventricular esquerda depois do enfarte do miocárdio
|
|
EP1966244B1
(en)
|
2005-12-30 |
2012-03-21 |
Merck Patent GmbH |
Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
|
|
WO2007116962A1
(ja)
|
2006-04-07 |
2007-10-18 |
Osaka University |
筋再生促進剤
|
|
TW200831528A
(en)
|
2006-11-30 |
2008-08-01 |
Astrazeneca Ab |
Compounds
|
|
EP2074146B1
(en)
*
|
2006-11-30 |
2013-08-07 |
Medlmmune Limited |
Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor
|
|
CN101646459B
(zh)
|
2007-01-23 |
2014-02-12 |
国立大学法人信州大学 |
慢性排斥反应抑制剂
|
|
US7906117B2
(en)
|
2007-05-21 |
2011-03-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
|
|
US8404235B2
(en)
|
2007-05-21 |
2013-03-26 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
US8178101B2
(en)
|
2007-05-21 |
2012-05-15 |
Alderbio Holdings Inc. |
Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
|
|
US8252286B2
(en)
|
2007-05-21 |
2012-08-28 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
US8062864B2
(en)
|
2007-05-21 |
2011-11-22 |
Alderbio Holdings Llc |
Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
|
|
ES2721753T3
(es)
|
2007-05-21 |
2019-08-05 |
Alderbio Holdings Llc |
Anticuerpos contra IL-6 y usos de los mismos
|
|
US9701747B2
(en)
|
2007-05-21 |
2017-07-11 |
Alderbio Holdings Llc |
Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
|
|
WO2009109584A1
(en)
*
|
2008-03-07 |
2009-09-11 |
Ferring International Center S. A. |
ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX
|
|
US8034344B2
(en)
*
|
2008-05-13 |
2011-10-11 |
Novimmune S.A. |
Anti-IL-6/IL-6R antibodies and methods of use thereof
|
|
JP5544290B2
(ja)
|
2008-06-05 |
2014-07-09 |
独立行政法人国立がん研究センター |
神経浸潤抑制剤
|
|
US8188235B2
(en)
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
|
US8632774B2
(en)
*
|
2008-07-02 |
2014-01-21 |
Emergent Product Development Seattle, Llc |
Antagonists of IL-6
|
|
EP2334330A4
(en)
*
|
2008-09-29 |
2013-05-15 |
Janssen Biotech Inc |
ANTI-CD147 ANTIBODIES, METHODS, AND USES
|
|
US8420089B2
(en)
|
2008-11-25 |
2013-04-16 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
JP5620918B2
(ja)
|
2008-11-25 |
2014-11-05 |
ブリストル・マイヤーズ スクイブ カンパニー |
アルブミンを上昇および／またはｃｒｐを低下させるためのｉｌ−６アンタゴニスト
|
|
US8323649B2
(en)
|
2008-11-25 |
2012-12-04 |
Alderbio Holdings Llc |
Antibodies to IL-6 and use thereof
|
|
US8992920B2
(en)
|
2008-11-25 |
2015-03-31 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of arthritis
|
|
US9452227B2
(en)
|
2008-11-25 |
2016-09-27 |
Alderbio Holdings Llc |
Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
|
|
US9212223B2
(en)
|
2008-11-25 |
2015-12-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
US8337847B2
(en)
|
2008-11-25 |
2012-12-25 |
Alderbio Holdings Llc |
Methods of treating anemia using anti-IL-6 antibodies
|
|
MX2011011044A
(es)
|
2009-04-22 |
2011-11-04 |
Merck Patent Gmbh |
Proteinas de fusion de anticuerpos con sitios de enlace de receptor fc neonatal (fcrn) modificados.
|
|
KR20160005143A
(ko)
*
|
2009-05-13 |
2016-01-13 |
젠자임 코포레이션 |
항-인간 ｃｄ52 면역글루불린
|
|
EP2464666B1
(en)
*
|
2009-07-15 |
2018-03-21 |
Eva Kovacs-Benke |
Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases
|
|
WO2011066371A2
(en)
|
2009-11-24 |
2011-06-03 |
Alder Biopharmaceuticals, Inc. |
Antibodies to il-6 and use thereof
|
|
MY161541A
(en)
*
|
2009-07-31 |
2017-04-28 |
Shin Maeda |
Cancer metastasis inhibitor
|
|
SG178348A1
(en)
*
|
2009-08-19 |
2012-03-29 |
Merck Patent Gmbh |
Antibodies for the detection of integrin complexes in ffpe material
|
|
US9775921B2
(en)
|
2009-11-24 |
2017-10-03 |
Alderbio Holdings Llc |
Subcutaneously administrable composition containing anti-IL-6 antibody
|
|
WO2011079308A2
(en)
|
2009-12-23 |
2011-06-30 |
Emergent Product Development Seattle, Llc |
Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof
|
|
HUE060454T2
(hu)
|
2010-05-28 |
2023-03-28 |
Chugai Pharmaceutical Co Ltd |
Daganatellenes T-sejt-választ fokozó szer
|
|
WO2012071561A2
(en)
|
2010-11-23 |
2012-05-31 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of anemia
|
|
US20140255405A1
(en)
|
2011-05-27 |
2014-09-11 |
Dutalys |
Removal of Monomeric Targets
|
|
ES2758884T3
(es)
|
2011-06-24 |
2020-05-06 |
Stephen D Gillies |
Proteínas de fusión de inmunoglobulina a través de cadena ligera y métodos de uso de ellas
|
|
WO2013019690A1
(en)
*
|
2011-07-29 |
2013-02-07 |
The Ohio State University |
Small molecule inhibitors of il-6 and uses thereof
|
|
WO2013059548A1
(en)
*
|
2011-10-19 |
2013-04-25 |
Sanofi |
Compositions and methods for treating cancer using jak2 inhibitor
|
|
AU2013342163B2
(en)
*
|
2012-11-08 |
2018-08-16 |
F. Hoffmann-La Roche Ltd |
IL-6 antagonists and uses thereof
|
|
WO2014165282A1
(en)
*
|
2013-03-12 |
2014-10-09 |
Institute of Arthritis Research, LLC |
Immunologically active polypeptide
|
|
AR095199A1
(es)
|
2013-03-15 |
2015-09-30 |
Genzyme Corp |
Anticuerpos anti-cd52
|
|
CN105722532A
(zh)
|
2013-09-13 |
2016-06-29 |
豪夫迈·罗氏有限公司 |
包含纯化的重组多肽的方法和组合物
|
|
BR112016004437A2
(pt)
|
2013-09-13 |
2017-10-17 |
Genentech Inc |
métodos de imunoteste e de seleção de linhagem de células, anticorpos e kit
|
|
CN103897061B
(zh)
*
|
2014-03-25 |
2017-06-16 |
宝船生物医药科技(上海)有限公司 |
阻断西妥昔单抗和egfr结合的抗体、其试剂盒及杂交瘤细胞
|
|
TWI713453B
(zh)
|
2014-06-23 |
2020-12-21 |
美商健生生物科技公司 |
干擾素α及ω抗體拮抗劑
|
|
DK4268843T3
(da)
*
|
2014-11-07 |
2025-11-10 |
F Hoffmann La Roche Ltd |
Forbedrede IL-6-antistoffer
|
|
RS61947B1
(sr)
*
|
2014-12-01 |
2021-07-30 |
Ferring Bv |
Davanje selektivnog inhibitora il-6-trans-signalizacije
|
|
EP3227325B1
(en)
*
|
2014-12-01 |
2024-04-10 |
Ferring B.V. |
Selective il-6-trans-signalling inhibitor compositions
|
|
MX380753B
(es)
|
2015-07-02 |
2025-04-01 |
Hoffmann La Roche |
Lactamas bicíclicas y métodos de uso de las mismas.
|
|
US20190046642A1
(en)
|
2016-02-23 |
2019-02-14 |
Eleven Biotherapeutics, Inc. |
Il-6 antagonist formulations and uses thereof
|
|
JP7349359B2
(ja)
|
2016-10-17 |
2023-09-22 |
エフ． ホフマン－ラ ロシュ アーゲー |
二環式ピリドンラクタム及びその使用方法。
|
|
US11072607B2
(en)
|
2016-12-16 |
2021-07-27 |
Genentech, Inc. |
Inhibitors of RIP1 kinase and methods of use thereof
|
|
SG11201906852XA
(en)
|
2017-02-01 |
2019-08-27 |
Univ Yale |
Treatment of diuretic resistance
|
|
JP7185884B2
(ja)
|
2017-05-02 |
2022-12-08 |
国立研究開発法人国立精神・神経医療研究センター |
Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法
|
|
EP3698808B1
(en)
|
2017-10-20 |
2025-01-01 |
Hyogo College Of Medicine |
Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
|
|
CN109867723B
(zh)
*
|
2017-12-05 |
2022-06-17 |
南京金斯瑞生物科技有限公司 |
抗人il6单克隆抗体及其制备方法和用途
|
|
SG11202006157VA
(en)
|
2018-01-05 |
2020-07-29 |
Corvidia Therapeutics Inc |
Methods for treating il-6 mediated inflammation without immunosuppression
|
|
EP3781571B1
(en)
|
2018-04-20 |
2024-01-17 |
F. Hoffmann-La Roche AG |
N-[4-oxo-2,3-dihydro-pyrido[3,2-b][1,4]oxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs)
|
|
US20200405883A1
(en)
|
2019-06-20 |
2020-12-31 |
Baxalta Incorporated |
Method of treatment with viral-based gene therapy
|
|
CN111057152B
(zh)
*
|
2019-12-11 |
2022-03-11 |
中国人民解放军第四军医大学 |
一种抗人IL-6Ra单克隆抗体及其应用
|
|
JP2023042974A
(ja)
*
|
2021-09-15 |
2023-03-28 |
シスメックス株式会社 |
抗サイトカイン抗体の抗原に対する親和性を向上させる方法、抗サイトカイン抗体の製造方法及び抗サイトカイン抗体
|
|
CN119080929B
(zh)
*
|
2023-06-05 |
2025-08-12 |
东莞市朋志生物科技有限公司 |
抗白介素6抗体、检测白介素6的试剂和试剂盒
|